Código 300310 (Harmonized System 2012 by 6 digits)
2021: US$23.1k, International Sales
2023: US$891k, International Purchases
In 2018, the states with the most international sales in Medicaments Containing Penicillins or Derivatives Thereof with the Structure of Penicillanic Acid or Streptomycins or Derivatives Thereof, not in Measured Doses or put up for Sale to the Retail were Jalisco (US$25.8k).
The states with the most international purchases in 2023 were Estado de México (US$109k).
In 2018, the main commercial destinations of Medicaments Containing Penicillins or Derivatives Thereof with the Structure of Penicillanic Acid or Streptomycins or Derivatives Thereof, not in Measured Doses or put up for Sale to the Retail were Honduras (US$10.5k), Costa Rica (US$7.6k), Bolivia (US$7.06k), and Italy (US$583).
The main commercial origins of Medicaments Containing Penicillins or Derivatives Thereof with the Structure of Penicillanic Acid or Streptomycins or Derivatives Thereof, not in Measured Doses or put up for Sale to the Retail in 2023 were China (US$109k).
In the global context, the main exporting countries of Medicaments Containing Penicillins or Derivatives Thereof with the Structure of Penicillanic Acid or Streptomycins or Derivatives Thereof, not in Measured Doses or put up for Sale to the Retail in 2022 were China (US$101M), United Kingdom (US$98.1M), and Belgium (US$39.3M). In the same year, the main importing countries of Medicaments Containing Penicillins or Derivatives Thereof with the Structure of Penicillanic Acid or Streptomycins or Derivatives Thereof, not in Measured Doses or put up for Sale to the Retail were Austria (US$46.2M), Italy (US$43.4M), and Algeria (US$42.9M).
The visualizations show the net balance of Medicaments Containing Penicillins or Derivatives Thereof with the Structure of Penicillanic Acid or Streptomycins or Derivatives Thereof, not in Measured Doses or put up for Sale to the Retail at the level of states and countries. Colors more similar to blue, indicate that the territory presented a higher level of international sales. Colors more similar to red, indicate that the territory presented a higher level of international purchases.
November, 2024: US$583k, International Purchases
In November 2024, international sales of Medicaments Containing Penicillins or Derivatives Thereof with the Structure of Penicillanic Acid or Streptomycins or Derivatives Thereof, not in Measured Doses or put up for Sale to the Retail were US$0, while international purchases reached US$583k. The above results in a trade balance of -US$583k.
Jalisco: US$25.8k, State with the Most International Sales (2018)
Honduras: US$10.5k, Main commercial destination (2018)
In 2018, the states with the highest international sales in Medicaments Containing Penicillins or Derivatives Thereof with the Structure of Penicillanic Acid or Streptomycins or Derivatives Thereof, not in Measured Doses or put up for Sale to the Retail were Jalisco (US$25.8k).
In 2018, the countries with the most international purchases from Mexico were Honduras (US$10.5k), Costa Rica (US$7.6k), Bolivia (US$7.06k), and Italy (US$583).
Estado de México: US$109k, State with the Most International Purchases (2023)
China: US$109k, Main Commercial Origin (2023)
In 2023, the states with the highest international in Medicaments Containing Penicillins or Derivatives Thereof with the Structure of Penicillanic Acid or Streptomycins or Derivatives Thereof, not in Measured Doses or put up for Sale to the Retail were Estado de México (US$109k).
The countries with the most international sales to Mexico in 2023 were China (US$109k).
The RCA-Complexity diagram compares the Revelead Comparative Advantages of states in Medicaments Containing Penicillins or Derivatives Thereof with the Structure of Penicillanic Acid or Streptomycins or Derivatives Thereof, not in Measured Doses or put up for Sale to the Retail and the Economic Complexity Index of each state.
RCA values greater than 1 indicate that the state has comparative advantages in Medicaments Containing Penicillins or Derivatives Thereof with the Structure of Penicillanic Acid or Streptomycins or Derivatives Thereof, not in Measured Doses or put up for Sale to the Retail. On the other hand, high levels of complexity (ECI) are associated with higher levels of income, potential for economic growth, lower income inequality and lower emissions.
The visualizations show the global market for Medicaments Containing Penicillins or Derivatives Thereof with the Structure of Penicillanic Acid or Streptomycins or Derivatives Thereof, not in Measured Doses or put up for Sale to the Retail. In both charts, Mexico stands out in order to identify its participation in the export and import market.
In 2022, the main exporting countries of Medicaments Containing Penicillins or Derivatives Thereof with the Structure of Penicillanic Acid or Streptomycins or Derivatives Thereof, not in Measured Doses or put up for Sale to the Retail were China (US$101M), United Kingdom (US$98.1M), and Belgium (US$39.3M). In the same year, the main importing countries for Medicaments Containing Penicillins or Derivatives Thereof with the Structure of Penicillanic Acid or Streptomycins or Derivatives Thereof, not in Measured Doses or put up for Sale to the Retail were Austria (US$46.2M), Italy (US$43.4M), and Algeria (US$42.9M).